Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA9 | Q16790 | 9/20 | 0.46 |
| ▸ | CA1 | P00915 | 7/20 | 0.46 |
| ▸ | CA2 | P00918 | 7/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | STAT3 | P40763 | 2/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | MTOR | P42345 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.46 |
| ▸ | GPR3 | P46089 | 1/20 | 0.39 |
| ▸ | PLCG2 | P16885 | 1/20 | 0.37 |
| ▸ | CA12 | O43570 | 5/20 | 0.35 |
| ▸ | NOX1 | Q9Y5S8 | 1/20 | 0.34 |
| ▸ | ELANE | P08246 | 1/20 | 0.31 |
| ▸ | CA4 | P22748 | 2/20 | 0.31 |
| ▸ | CA7 | P43166 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31003510 | 1.00 | CA9 (0.46) | CA9CA1CA2KMT2AMEN1 | |
| Water SCHEMBL27659746 | 0.98 | CA9 (0.44) | CA9CA1CA2KMT2AMEN1 | |
| Methoxymethane SCHEMBL10856175 | 0.91 | CA9 (0.41) | CA9CA1CA2KMT2AMEN1 | |
| Acetone SCHEMBL8996477 | 0.88 | CA9 (0.39) | CA9CA1CA2KMT2AMEN1 | |
| Thiophene SCHEMBL28465488 | 0.88 | MEN1 (0.42) | CA9CA1CA2KMT2AMEN1 | |
| SCHEMBL386507 | 0.84 | GPR3 (0.34) | CA9CA1CA2KMT2AMEN1 | |
| SCHEMBL19744948 | 0.82 | GPR3 (0.48) | CA9CA1CA2KMT2AMEN1 | |
| Cyclohexylamine SCHEMBL4918979 | 0.80 | CA1 (0.37) | CA9CA1CA2KMT2AMEN1 | |
| Valine SCHEMBL11636707 | 0.77 | SLC7A5 (0.44) | CA9CA1CA2KMT2AMEN1 | |
| Cyclohexane Carboxamide SCHEMBL204775 | 0.76 | SIRT2 (0.38) | CA9CA1CA2KMT2APLCG2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1770 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-121584026-A | Ion polarization enhancement type local high-concentration electrolyte and application thereof in lithium ion battery | 国网湖南省电力有限公司 | 2026-02-27 | — | — | CN | claimed |
| WO-2025129023-A1 | INDOLE AMIDE AND RELATED COMPOUNDS AND THEIR USE IN TREATING MEDICAL CONDITIONS | RECTIFY PHARMACEUTICALS, INC. (US) | 2025-06-19 | — | — | WO | claimed |
| CN-116041363-B | Benzothiophene sulfone organic crystal, preparation and application as photocatalyst | 华中科技大学 | 2025-02-11 | — | — | CN | claimed |
| US-20240400591-A1 | COMPOUNDS TARGETING MUTANT OF P53 | JACOBIO PHARMACEUTICALS CO., LTD. (CN) | 2024-12-05 | — | — | US | claimed |
| US-20240150508-A1 | PHOTO-SWITCHABLE CHEMISTRY FOR REVERSIBLE HYDROGELS AND REUSABLE FLOW CELLS | ILLUMINA, INC. (US) | 2024-05-09 | — | — | US | claimed |
| CN-117903781-A | Visible light excited organic long afterglow material, three-dimensional structure, preparation method and application thereof | 西北工业大学 | 2024-04-19 | — | — | CN | claimed |
| WO-2024081563-A1 | PHOTO-SWITCHABLE CHEMISTRY FOR REVERSIBLE HYDROGELS AND REUSABLE FLOW CELLS | ILLUMINA, INC. (US) | 2024-04-18 | — | — | WO | claimed |
| CN-117552024-A | Preparation method of nonmetal-catalyzed 2, 3-dihydrobenzo [ b ] thiophene 1, 1-dioxide | 青岛科技大学 | 2024-02-13 | — | — | CN | claimed |
| CN-116041366-B | Chiral 3-spiro-oxindole benzothiophene sulfone derivative, preparation method and application thereof | 成都大学 | 2023-12-22 | — | — | CN | claimed |
| CN-117126130-A | Method for preparing 2-aryl benzothiophene sulfone by utilizing oxidative Suzuki coupling reaction | 浙江师范大学 | 2023-11-28 | — | — | CN | claimed |
| CN-1320121-A | Substituted 3-cyanoquinolines as protein tyrosine kinase inhibitors | AMERICAN CYANAMID CO (US) | 2001-10-31 | — | — | CN | claimed |
| US-6288082-B1 | COMPOUNDS SUCH AS 6,7-DIETHOXY-4-(INDAN-5-YLAMINO) -QUINOLINE-3-CARBONITRILE USED AS ANTINEOPLASTIC AGENTS AND IN THE TREATMENT OF POLYCYCSTIC KIDNEY DISEASE | AMERICAN CYANAMID COMPANY | 2001-09-11 | — | — | US | claimed |
| EP-1117659-A1 | SUBSTITUTED 3-CYANOQUINOLINES AS PROTEIN TYROSINE KINASES INHIBITORS | American Cyanamid Company (US) | 2001-07-25 | — | — | EP | claimed |
| EP-1067128-A1 | FUSED THIOPHENE DERIVATIVES AND DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT | ONO PHARMACEUTICAL CO., LTD. (JP) | 2001-01-10 | — | — | EP | claimed |
| US-6133279-A | A 2,6-DI-T-BUTYLPHENOL DERIVATIVE FOR RENAL DISEASES, E.G., CHRONIC RENAL FAILURE, DIABETIC NEPHROPATHY GLOMERULAR NEPHRITIS, IMMUNOCOMPLEX NEPHRITIS AND ACUTE RENAL FAILURE; CYTOPROTECTIVE AGENT THAT INHIBITS THE LIPID PEROXIDATION | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2000-10-17 | — | — | US | claimed |
| US-6103753-A | ADMINISTERING TO A PATIENT FOR INHIBITING THICKENING OF VASCULAR STENOSIS FOLLOWING PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY, A 2,6-DI-T-BUTYLPHENOL DERIVATIVE | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2000-08-15 | — | — | US | claimed |
| WO-2000018761-A1 | SUBSTITUTED 3-CYANOQUINOLINES AS PROTEIN TYROSINE KINASES INHIBITORS | AMERICAN CYANAMID COMPANY (US) | 2000-04-06 | — | — | WO | claimed |
| EP-0950405-A1 | REMEDIES FOR RENAL DISEASES AND ORGAN-PRESERVING AGENTS | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 1999-10-20 | — | — | EP | claimed |
| EP-0868913-A1 | INTIMAL THICKENING INHIBITOR | Chugai Seiyaku Kabushiki Kaisha (JP) | 1998-10-07 | — | — | EP | claimed |
| US-3960677-A | CARBOXY TERMINATED ANIONIC WETTING AGENT, FURAN, THIOPHENE, OR THIAZOLE BRIGHTNER | THE HARSHAW CHEMICAL COMPANY (US) | 1976-06-01 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240400591-A1 | COMPOUNDS TARGETING MUTANT OF P53 | TP53, TP53BP1, MDM2 | CA9 3658/4885CA1 2782/4885CA2 3601/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.